Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks

Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks

Health Industry Hub | December 11, 2024 |

Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]

More

News & Trends - Pharmaceuticals

BeiGene's BTK inhibitor delivers promising long-term results in newly released data

BeiGene’s BTK inhibitor delivers promising long-term results in newly released data

Health Industry Hub | December 11, 2024 |

Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]

More

News & Trends - Pharmaceuticals

UCB nabs TGA approval for first dual action anti-seizure therapy

UCB nabs TGA approval for first dual action anti-seizure therapy

Health Industry Hub | December 10, 2024 |

UCB Australia has secured Therapeutic Goods Administration (TGA) approval for the first dual action anti seizure medicine, Fintepla (fenfluramine). The […]

More

News & Trends - Pharmaceuticals

AstraZeneca’s SGLT-2 inhibitor PBS listed for patients with type 2 diabetes and high cardiovascular risk

AstraZeneca’s SGLT-2 inhibitor PBS listed for patients with type 2 diabetes and high cardiovascular risk

Health Industry Hub | December 9, 2024 |

More than 100,000 Australians living with type 2 diabetes and high cardiovascular risk will gain earlier access to AstraZeneca’s SGLT-2 […]

More

News & Trends - Pharmaceuticals

'Expertise, innovation and community' fuel launch of Heart Health Collective

‘Expertise, innovation and community’ fuel launch of Heart Health Collective

Health Industry Hub | December 6, 2024 |

Cardiovascular disease (CVD) remains the leading cause of death and disease burden in Australia, affecting over 4.2 million people and […]

More

News & Trends - Pharmaceuticals

Access to 'affordable healthcare' surges in national priorities amid delays to HTA reforms

Access to ‘affordable healthcare’ surges in national priorities amid delays to HTA reforms

Health Industry Hub | December 5, 2024 |

Access to “quality affordable” healthcare has emerged as the second most important national priority for Australians, just behind the cost […]

More

News & Trends - Pharmaceuticals

The urgency of restoring public trust: Pfizer's Medical Director talks the essentials in prevention and health reforms

The urgency of restoring public trust: Pfizer’s Medical Director addresses the essentials in prevention and health reforms

Health Industry Hub | December 4, 2024 |

The erosion of public trust in government and medical science emerged as a stark challenge revealed by the year-long COVID-19 […]

More

News & Trends - Pharmaceuticals

PBAC and MSAC Chairs raise concerns, threatening more delays to HTA reforms

PBAC and MSAC Chairs voice concerns, threatening more delays to HTA reforms

Health Industry Hub | December 3, 2024 |

Sharp concerns from the Chairs of the Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC) have surfaced […]

More

News & Trends - Pharmaceuticals

Why is HTA undermining the value of patient preference data in decision-making?

Why is HTA undermining the value of patient preference data in decision-making?

Health Industry Hub | December 2, 2024 |

The potential value of patient preference (PP) data in health technology assessment (HTA) is widely acknowledged. Yet, despite growing calls […]

More

News & Trends - Pharmaceuticals

PBS listing of Bayer's endometriosis therapy ends a 30-year wait, marking a milestone in women’s health

PBS listing of Bayer’s endometriosis therapy ends a 30-year wait, marking a milestone in women’s health

Health Industry Hub | December 2, 2024 |

Australians living with endometriosis, a chronic and debilitating condition causing severe pain and infertility, now have subsidised access to Bayer’s […]

More

News & Trends - Pharmaceuticals

March PBAC agenda unveiled amid tensions over 'unprecedented' volume of submissions

March PBAC agenda unveiled amid tensions over ‘unprecedented’ volume of submissions

Health Industry Hub | November 29, 2024 |

The Department of Health has released the agenda for the March 2025 Pharmaceutical Benefits Advisory Committee (PBAC) meeting, unveiling plans […]

More

Recent Posts in Pharma, MedTech & Biotech

Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks
By Health Industry Hub
December 11, 2024 in News & Trends - Pharmaceuticals

‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia
By Health Industry Hub
December 11, 2024 in News & Trends - MedTech & Diagnostics

BeiGene’s BTK inhibitor delivers promising long-term results in newly released data
By Health Industry Hub
December 11, 2024 in News & Trends - Pharmaceuticals

Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist
By Health Industry Hub
December 10, 2024 in Communication

Health insurers must refund gouged members’ profits: APHA CEO urges Health Minister to take firm action
By Health Industry Hub
December 10, 2024 in News & Trends - MedTech & Diagnostics

MTAA announces new Board Chair and Vice Chairs
By Health Industry Hub
December 10, 2024 in News & Trends - MedTech & Diagnostics

UCB nabs TGA approval for first dual action anti-seizure therapy
By Health Industry Hub
December 10, 2024 in News & Trends - Pharmaceuticals

Health Minister’s warning to private health insurers: ‘Stop this practice immediately, or I’ll force you to stop’
By Health Industry Hub
December 9, 2024 in News & Trends - MedTech & Diagnostics

  • Follow Us

  • Partner with us

    Build thought leadership, differentiate your organisation and let us help you connect with Pharma, MedTech, Diagnostics and Biotech industry professionals.

    To find out how you can engage with Health Industry Hub’s audience click here.

  • News & Trends - Pharmaceuticals

    Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks

    Lilly and Boehringer attract local trials to tackle obesity and its cardiovascular risks

    Health Industry Hub | December 11, 2024 |

    Obesity remains a pressing public health issue, serving as a key driver of numerous complications, including atherosclerotic cardiovascular disease (ASCVD) […]

    More


    News & Trends - MedTech & Diagnostics

    'We need relief now, we can't wait for another talk fest,' asserts CEO of Day Hospitals Australia

    ‘We need relief now; we can’t wait for another talkfest,’ asserts CEO of Day Hospitals Australia

    Health Industry Hub | December 11, 2024 |

    The private healthcare sector is grappling with escalating tensions between private hospitals and health insurers, with no resolution in sight. […]

    More


    News & Trends - Pharmaceuticals

    BeiGene's BTK inhibitor delivers promising long-term results in newly released data

    BeiGene’s BTK inhibitor delivers promising long-term results in newly released data

    Health Industry Hub | December 11, 2024 |

    Bruton tyrosine kinase (BTK) inhibitors have improved treatment outcomes for patients with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma […]

    More


    Communication

    Mastering the art of saying 'No' to protect your career and well-being: Psychologist

    Mastering the art of saying ‘No’ to protect your career and well-being: Psychologist

    Health Industry Hub | December 10, 2024 |

    As the year draws to a close, professionals and leaders alike are faced with increasing pressure to meet deadlines, complete […]

    More


    This content is copyright protected. Please subscribe to gain access.